Teladoc Health, Inc. (4LL.F)
EUR 6.45
(2.01%)
EUR 6.45
(2.01%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -220.36 Million USD | 98.39% |
| 2022 | -13.65 Billion USD | -3085.58% |
| 2021 | -428.79 Million USD | 11.61% |
| 2020 | -485.13 Million USD | -390.71% |
| 2019 | -98.86 Million USD | -1.83% |
| 2018 | -97.08 Million USD | 9.08% |
| 2017 | -106.78 Million USD | -43.88% |
| 2016 | -74.21 Million USD | -27.91% |
| 2015 | -58.02 Million USD | -240.55% |
| 2014 | -17.03 Million USD | -183.05% |
| 2013 | -6.01 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -81.88 Million USD | -183.45% |
| 2024 Q2 | -837.67 Million USD | -922.93% |
| 2023 Q1 | -69.22 Million USD | 98.18% |
| 2023 Q3 | -57.07 Million USD | 12.43% |
| 2023 Q2 | -65.17 Million USD | 5.85% |
| 2023 FY | -220.36 Million USD | 98.39% |
| 2023 Q4 | -28.89 Million USD | 49.38% |
| 2022 FY | -13.65 Billion USD | -3085.58% |
| 2022 Q4 | -3.81 Billion USD | -5085.46% |
| 2022 Q1 | -6.67 Billion USD | -60660.34% |
| 2022 Q2 | -3.1 Billion USD | 53.53% |
| 2022 Q3 | -73.47 Million USD | 97.63% |
| 2021 Q1 | -199.64 Million USD | 49.32% |
| 2021 Q4 | -10.98 Million USD | 86.98% |
| 2021 Q2 | -133.81 Million USD | 32.97% |
| 2021 Q3 | -84.34 Million USD | 36.97% |
| 2021 FY | -428.79 Million USD | 11.61% |
| 2020 Q3 | -35.88 Million USD | -39.72% |
| 2020 Q4 | -393.96 Million USD | -997.89% |
| 2020 Q2 | -25.68 Million USD | 13.25% |
| 2020 FY | -485.13 Million USD | -390.71% |
| 2020 Q1 | -29.6 Million USD | -55.45% |
| 2019 Q1 | -30.15 Million USD | -21.19% |
| 2019 Q3 | -20.34 Million USD | 30.62% |
| 2019 Q4 | -19.04 Million USD | 6.4% |
| 2019 FY | -98.86 Million USD | -1.83% |
| 2019 Q2 | -29.32 Million USD | 2.74% |
| 2018 Q4 | -24.87 Million USD | -6.94% |
| 2018 FY | -97.08 Million USD | 9.08% |
| 2018 Q3 | -23.26 Million USD | 7.24% |
| 2018 Q2 | -25.07 Million USD | -5.1% |
| 2018 Q1 | -23.86 Million USD | 46.24% |
| 2017 Q3 | -31.33 Million USD | -103.24% |
| 2017 Q2 | -15.41 Million USD | 1.53% |
| 2017 Q4 | -44.38 Million USD | -41.66% |
| 2017 FY | -106.78 Million USD | -43.88% |
| 2017 Q1 | -15.65 Million USD | -9.77% |
| 2016 Q2 | -14.87 Million USD | 2.78% |
| 2016 Q4 | -14.26 Million USD | 52.1% |
| 2016 FY | -74.21 Million USD | -27.91% |
| 2016 Q3 | -29.77 Million USD | -100.09% |
| 2016 Q1 | -15.3 Million USD | -1.98% |
| 2015 FY | -58.02 Million USD | -240.55% |
| 2015 Q4 | -15 Million USD | -13.29% |
| 2015 Q3 | -13.24 Million USD | 22.37% |
| 2015 Q2 | -17.06 Million USD | -34.33% |
| 2015 Q1 | -12.7 Million USD | -81.65% |
| 2014 FY | -17.03 Million USD | -183.05% |
| 2014 Q2 | -3.2 Million USD | -38.29% |
| 2014 Q3 | -4.52 Million USD | -41.53% |
| 2014 Q4 | -6.99 Million USD | -54.4% |
| 2014 Q1 | -2.31 Million USD | 0.0% |
| 2013 FY | -6.01 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| DocCheck AG | 2.27 Million EUR | 9801.576% |
| CompuGroup Medical SE & Co. KGaA | 45.91 Million EUR | 579.937% |
| MeVis Medical Solutions AG | 4.91 Million EUR | 4579.438% |
| Nexus AG | 24.03 Million EUR | 1017.016% |